Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Maria Teresa Landi | |
|---|---|
 | |
| Alma mater | University of Milan Italian University Consortium |
| Scientific career | |
| Fields | Cancer epidemiology, genomics, environmental health |
| Institutions | National Cancer Institute Johns Hopkins Bloomberg School of Public Health |
Life
editLandi completed an M.D. summa cum laude from the University of Milan and was trained in oncology and general medicine at the San Raffaele Hospital.[1] She earned a Ph.D. in occupational medicine and industrial hygiene, a subgroup of molecular epidemiology, from an Italian University Consortium in 1993. Landi qualified for the associate professorship in occupational medicine and industrial hygiene in the Italian Universities in 1998.[1]
Landi received tenure in the National Cancer Institute's division of cancer epidemiology and genetics (DCEG) in 2006.[2] She is a senior investigator in the integrative tumor epidemiology branch.[1] She is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. Landi and her team conduct germline and somatic genomic analyses in population studies.[2] In 2021, she was appointed senior advisor for genomic epidemiology in DCEG's trans-divisional research program.[2] Landi's research focuses on understanding tumor etiology and evolution for potential translational applications. She leads large-scale multidisciplinary research projects primarily on genetic and environmental determinants of lung cancer and melanoma.[2] Landi conducts analyses of genomic, transcriptomic, and epigenomic data, and integrates molecular data with histological and radiological imaging and clinical and epidemiological data.[2] She also examines the role of dioxins in cancer risk among highly exposed populations, utilizing markers of exposure and early effect.[2]
See also
editReferences
edit- ^ a b c "Principal Investigators". NIH Intramural Research Program. Retrieved 2022-10-14.
This article incorporates text from this source, which is in the public domain.
- ^ a b c d e f "Maria Teresa Landi, M.D., Ph.D., biographical sketch and research interests - NCI". dceg.cancer.gov. 1980-01-01. Retrieved 2022-10-14. This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.